DOCSLIB.ORG

Sprawozdanie 2018 2.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sprawozdanie 2018 2.Pdf 1 2 SPRAWOZDANIE Z DZIAŁALNOŚCI INSTYTUTU ZA ROK 2018 Opracowano w Dziale Zarządzania Wiedzą Łódź, 2019 3 4 Spis treści I. O INSTYTUCIE .................................................................................................................... 9 1. Struktura organizacyjna (według stanu na dzień 31.12.2018 r.) ................................................. 9 2. Rada Naukowa (wg stanu na dzień 31.12.2018 r.) .................................................................... 14 3. Kadra (wg stanu na dzień 31.12.2018 r.) ................................................................................... 21 II. STRUKTURA ZADAŃ ......................................................................................................... 27 1. Główne kierunki badawcze ....................................................................................................... 27 2. Realizacja zadań według podstawowych źródeł finansowania ................................................. 28 3. Komisja Bioetyczna .................................................................................................................... 30 III. OSIĄGNIĘCIA W ZAKRESIE DZIAŁALNOŚCI NAUKOWO-BADAWCZEJ .................................. 33 1. Potencjał naukowy .................................................................................................................... 33 a. Uprawnienia do nadawania stopni naukowych .................................................................... 33 b. Rozwój kadry naukowej ......................................................................................................... 33 c. Funkcje we władzach krajowych i międzynarodowych towarzystw naukowych .................. 39 d. Udział w zespołach eksperckich ............................................................................................ 42 e. Redakcje czasopism (redaktorzy naczelni) ............................................................................ 52 f. Członkowstwo w zespołach redakcyjnych ............................................................................. 52 2. Osiągnięcia naukowe ................................................................................................................. 55 a. Dorobek publikacyjny ............................................................................................................ 55 b. Najważniejsze osiągnięcia naukowe udokumentowane publikacjami o zasięgu międzynarodowym ........................................................................................................................ 57 c. Nagrody i wyróżnienia ........................................................................................................... 74 3. Upowszechnianie wiedzy .......................................................................................................... 75 a. Działalność szkoleniowa ........................................................................................................ 75 b. Realizacja zasad otwartości w nauce..................................................................................... 78 c. Organizacja konferencji, seminariów .................................................................................... 79 IV. STRESZCZENIA WYKONANYCH PRAC NAUKOWO-BADAWCZYCH ....................................... 83 V. WSPÓŁPRACA NAUKOWA Z ZAGRANICĄ ......................................................................... 185 1. Międzynarodowe programy naukowe trwające i rozpoczęte w 2018 r. ................................. 185 a. Kontrakty realizowane i rozliczone w ramach Programów Ramowych Unii Europejskiej .. 185 b. Pozostałe programy ............................................................................................................. 186 VI. SYSTEMY ZARZĄDZANIA JAKOŚCIĄ W LABORATORIACH .................................................. 189 1. Akredytacja .............................................................................................................................. 192 2. Dobra Praktyka Laboratoryjna (DPL) ....................................................................................... 192 5 3. Dobra Praktyka Wytwarzania (DPW)....................................................................................... 193 4. Badania biegłości ..................................................................................................................... 193 VII. DZIAŁALNOŚĆ KLINICZNA ................................................................................................ 197 1. Klinika Audiologii i Foniatrii ..................................................................................................... 197 2. Klinika Toksykologii.................................................................................................................. 198 a. Oddział Toksykologii ............................................................................................................ 198 b. Pracownia Diagnostyki Toksykologicznej ............................................................................ 198 3. Klinika Chorób Zawodowych i Zdrowia Środowiskowego ....................................................... 199 a. Oddział Chorób Zawodowych .............................................................................................. 199 b. Przychodnia Chorób Zawodowych i Centrum Ochrony Zdrowia Pracujących .................... 200 c. Pracownia Diagnostyki Alergologicznej i Chorób Zawodowych .......................................... 201 d. Pracownia Dermatologii ...................................................................................................... 202 VIII. NAUKOWE BAZY DANYCH ............................................................................................... 205 1. Krajowe rejestry danych .......................................................................................................... 205 2. Bazy Faktograficzne ................................................................................................................. 207 3. Bazy bibliograficzne i repozytoria ............................................................................................ 208 IX. WYDAWNICTWA NAUKOWE ........................................................................................... 213 1. Dwumiesięcznik „Medycyna Pracy” ........................................................................................ 213 2. Dwumiesięcznik „International Journal of Occupational Medicine and Environmental Health” 214 X. BUDŻET .......................................................................................................................... 221 XI. ZAŁĄCZNIKI .................................................................................................................... 224 1. Wykaz publikacji ...................................................................................................................... 224 2. Wykaz wyjazdów krajowych i zagranicznych .......................................................................... 239 3. Wizyty gości zagranicznych ..................................................................................................... 268 6 7 8 I. O INSTYTUCIE 1. Struktura organizacyjna (według stanu na dzień 31.12.2018 r.) Lp. Jednostka organizacyjna Obsada KADRA ZARZĄDZAJĄCA - DYREKCJA 1. DYREKTOR prof. dr hab. med. Konrad Rydzyński 2. Z-CA DYREKTORA ds. NAUKOWYCH prof. dr hab. med. Wojciech Hanke Z-CA DYREKTORA ds. MEDYCZNYCH I ROZWOJU 3. KADR NAUKOWYCH Z-CA DYREKTORA ds. EKONOMICZNO- 4. mgr inż. Barbara Jurewicz FINANSOWYCH - GŁÓWNY KSIĘGOWY Z-CA DYREKTORA ds. INNOWACJI 5. I WDROŻEŃ DZIAŁALNOŚĆ NAUKOWA 6. PEŁNOMOCNIK DYREKTORA ds. JAKOŚCI dr Danuta Ligocka 7. Biuro Zapewnienia Jakości Krajowe Centrum Promocji Zdrowia w Miejscu 8. dr Elżbieta Korzeniowska Pracy Zakład Epidemiologii Środowiskowej 9. prof. dr hab. med. Wojciech Hanke Centralny Rejestr Chorób Zawodowych Pracownia Epidemiologii dr hab. med. Beata Pepłońska prof. IMP Pracownia Środowiskowych Zagrożeń Reprodukcji dr hab. Joanna Jurewicz prof. IMP Pracownia Środowiskowych Zagrożeń Zdrowia dr hab. Kinga Polańska prof. IMP Dzieci Ośrodek Referencyjny Badań i Oceny Ryzyka dr hab. Beata Świątkowska prof. IMP Zdrowotnego Związanych z Azbestem 10. Zakład Fizjologii Pracy i Ergonomii prof. dr hab. Alicja Bortkiewicz Pracownia Badań nad Snem dr Jadwiga Siedlecka 11. Zakład Psychologii Zdrowia i Pracy dr hab. Dorota Merecz-Kot prof. IMP Pracownia Stresu Zawodowego Pracownia Diagnostyki Psychologicznej dr Małgorzata Waszkowska Laboratorium Badań Produktów Leczniczych 12. dr Joanna Piasecka-Zelga i Weterynaryjnych w Systemie Jakości GMP Zakład Toksykologii i Kancerogenezy Pracownia Oceny Toksyczności dr hab. med. Maciej Stępnik prof. IMP 13. Krajowe Centrum Metod Alternatywnych do Oceny Toksyczności Pracownia Toksykologii Molekularnej dr Joanna Roszak 9 14. Zakład Genetyki Molekularnej i Epigenetyki dr hab. Edyta Reszka prof. IMP 15. Zakład Monitoringu Biologicznego i Środowiska prof. dr hab. Wojciech Wąsowicz Pracownia Analiz Metali dr hab. Beata Janasik prof. IMP Pracownia Biochemii i Monitoringu prof. dr hab. Jolanta Gromadzińska Środowiskowego Substancji Organicznych Zakład Bezpieczeństwa Chemicznego 16. prof. dr hab. Sławomir Czerczak Pracownia Szacowania Ryzyka Zdrowotnego 17. Zakład Ochrony Radiologicznej prof. dr hab. Marek Zmyślony 18. PEŁNOMOCNIK DYREKTORA ds. DOZYMETRII dr Joanna Domienik-Andrzejewska Pracownia Oceny Narażenia Populacji Pracownia Oceny Narażenia Zawodowego dr
Load more

Recommended publications
  • Teri Melese, Ph.D
    Prepared: 02/015 University of California, San Diego Curriculum Vitae Name: Teri Melese, Ph.D Current Position: UCSD Assistant Vice Chancellor, Industry Research Alliances Adjunct Associate Professor, Department of Medicine and Rady School of Management Last Position Held: Adjunct Associate Professor UCSF Department of Medicine, School of Medicine, 2005-2012 UCSF Dean’s Office: Director of Business Strategy and Development, School of Medicine UCSF Helen Diller Comprehensive Cancer Center Executive Committee: Associate Director for Strategic Alliances Address: University of California, San Diego Office of Research Affairs 9500 Gilman Drive #0910 La Jolla, CA 92093-0043 Tel: (858) 822-5247 mobile: (408) 373-3651 [email protected] Education: 1975-77 University of California, Berkeley A.B. Neurobiology/ Literature 1977-82 University of California, San Francisco Ph.D. Regents Fellow 1982-86 University of California, Los Angeles Postdoctoral Fellow Biochemistry 1986-87 University of California, Los Angeles American Cancer Sr. Research Fellow Molecular Biology Principal Positions Held: 1988-92 Columbia University, New York Assistant Professor Biological Sciences 1993-97 Columbia University, New York Associate Professor Biological Sciences 1997-99 Columbia University, New York Adjunct Associate Professor Biological Sciences 1997-01 Iconix Pharmaceuticals Mountain View Founding Member & Director Chemical Genomics 2001-2012 University of California, San Francisco Adjunct Full Professor Step II Medicine Present University of California, San Diego
    [Show full text]
  • Molecular Chaperones in Cancer
    CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER IN MEMORY OF SUSAN LINDQUIST Organisers Nabil Djouder Spanish National Cancer Research Centre (CNIO), Madrid, Spain Wilhelm Krek Institute for Molecular Health Sciences Zurich, Switzerland Paul Workman The Institute of Cancer Research London, UK Xiaohong Helena Yang Cancer Cell Cambridge, US EXCELENCIA MINISTERIO DE ECONOMÍA, INDUSTRIA SEVERO Y COMPETITIVIDAD OCHOA CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER Summary 07 PROGRAMME 19 KEYNOTE LECTURE 23 SESSIONS 23 S #1 PROTEIN QUALITY CONTROL 31 S #2 FOLDING, MISFOLDING AND AGGREGATION 41 S #3 STRESS MECHANISMS IN CANCER 49 S #4 CHAPERONES IN CANCER 59 S #5 TARGETING CHAPERONES: CHAPERONOTHERAPY 67 CLOSING LECTURE 69 ORGANISERS AND SPEAKERS’ BIOGRAPHIES 99 POSTER SESSIONS 119 Previous CNIO Frontiers Meetings and CNIO Cancer Conferences 05 CNIO - SPANISH”LA CAIXA”NATIONAL CANCER FOUNDATION RESEARCH CENTRE FRONTIERS MEETINGS 2017 Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER PROGRAMME 07 PROGRAMME Madrid 2nd- 4th May 2017 MOLECULAR CHAPERONES IN CANCER Venue: Spanish National Cancer Research Centre – CNIO Auditorium, Madrid, Spain Chairpersons and organizing committee: Nabil Djouder, Spanish National Cancer Research Centre, Madrid, Spain Wilhelm Krek, Institute for Molecular Health Sciences, ETH, Zurich, Switzerland Paul Workman, The Institute of Cancer Research, London, UK Xiaohong Helena Yang, Cancer Cell, Cambridge, USA Rationale: Molecular chaperones play key roles in the folding, stability and activity of proteins in normal cell homeostasis and disease pa- thology, including cancer.
    [Show full text]
  • New Frontiers
    PROGRAM & BOOK OF ABSTRACTS JUNE 13-16, 2009 • PORTLAND, OREGON New Frontiers Children’s Tumor FoundaTION 95 PINE STREET, 16TH FLOOR, NEW YORK, NY 10005 | WWW.CTF.ORG | 212.344.6633 Dear NF Conference Attendees: On behalf of the Children’s Tumor Foundation, welcome to the 2009 NF Conference: New Frontiers. The theme references the meeting content and also Portland itself, historically a gateway port of the Pacific North West. The urban setting offers a ‘new frontier’ in comparison to the mountain and beach locales of past NF Conferences, but one which we feel you will enjoy. Portland is an easy-going city offering history, beauty and relaxation – features encapsulated in our host hotel The Nines, itself a part of the tapestry of Portland history, renovated from the former landmark Meier & Frank department store. The last year has seen major NF research advances. The dovetailing of discovery, translation and the clinic can be seen throughout the meeting. We are firmly in the age of NF clinical trials and proud that the Children’s Tumor Foundation is part of this advance: in 2009 we funded our first two pilot Clinical Trial Awards. We continue to build a pipeline of candidate NF drug therapies through the Foundation’s multi-center NF Preclinical Consortium and the seed grant Drug Discovery Initiative (DDI) program. Through these translational initiatives we are cultivating NF collaborations with the biotechnology and pharmaceutical sector, a critical factor in moving NF research forward to the clinic. At the same time, basic research advances continue, such as in the unraveling of schwannomatosis.
    [Show full text]
  • LONG-TERM MEMBERS 25+ Years of Membership
    LONG-TERM MEMBERS 25+ Years of Membership Stuart A. Aaronson, MD Stephen P. Ackland, MBBS Carol Aghajanian, MD Steven A. Akman, MD Icahn School of Medicine at Mount Sinai University of Newcastle Memorial Sloan Kettering Cancer Center Roper St. Francis Healthcare United States Australia United States United States Active Member Active Member Active Member Active Member 38 Years of Membership 33 Years of Membership 27 Years of Membership 35 Years of Membership Cory Abate-Shen, PhD Edward M. Acton, PhD Irina U. Agoulnik, PhD Emmanuel T. Akporiaye, PhD Columbia University Irving Medical United States Florida International University Verana Therapeutics Center Emeritus Member United States United States United States 42 Years of Membership Active Member Emeritus Member Active Member 25 Years of Membership 31 Years of Membership 26 Years of Membership David J. Adams, PhD Duke University Medical Center Imran Ahmad, PhD Ala-Eddin Al Moustafa, PhD James L. Abbruzzese, MD United States Northwestern Medicine McGill University Duke University Emeritus Member United States Canada United States 32 Years of Membership Active Member Active Member Active Member 25 Years of Membership 26 Years of Membership 32 Years of Membership Gregory P. Adams, PhD Elucida Oncology Nihal Ahmad, PhD Abdul Al Saadi, PhD Ehtesham A. Abdi, MBBS United States Univ. of Wisconsin Madison Sch. of Med. William Beaumont Hospital The Tweed Hospital Active Member & Public Health United States Australia 29 Years of Membership United States Emeritus Member Emeritus Member Active Member 52 Years of Membership 33 Years of Membership Lucile L. Adams-Campbell, PhD 25 Years of Membership Georgetown Lombardi Comprehensive Suresh K.
    [Show full text]
  • This Electronic Thesis Or Dissertation Has Been Downloaded from Explore Bristol Research
    This electronic thesis or dissertation has been downloaded from Explore Bristol Research, http://research-information.bristol.ac.uk Author: Marcolino De Assis Junior, Eudmar Title: The regulation of PRH/HHEX by transforming growth factor General rights Access to the thesis is subject to the Creative Commons Attribution - NonCommercial-No Derivatives 4.0 International Public License. A copy of this may be found at https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode This license sets out your rights and the restrictions that apply to your access to the thesis so it is important you read this before proceeding. Take down policy Some pages of this thesis may have been removed for copyright restrictions prior to having it been deposited in Explore Bristol Research. However, if you have discovered material within the thesis that you consider to be unlawful e.g. breaches of copyright (either yours or that of a third party) or any other law, including but not limited to those relating to patent, trademark, confidentiality, data protection, obscenity, defamation, libel, then please contact [email protected] and include the following information in your message: •Your contact details •Bibliographic details for the item, including a URL •An outline nature of the complaint Your claim will be investigated and, where appropriate, the item in question will be removed from public view as soon as possible. The regulation of PRH/HHEX by transforming growth factor β By Eudmar Marcolino de Assis Junior A thesis submitted to the University of Bristol, School of Biochemistry, for the degree of Doctor of Philosophy Word count: 56,442 ABSTRACT The transcription factor PRH/HHEX (Proline-Rich Homeodomain/Haematopoietically Expressed Homeobox) controls cell proliferation, cell differentiation and cell migration/invasion in a diverse range of cell types.
    [Show full text]
  • Acknowledgment of Reviewers, 2016
    Acknowledgment of Reviewers, 2016 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2016. Their generous contribution is deeply appreciated. A Lia Addadi Edoardo Airoldi Kathleen A. Alexander Rommie E. Amaro Lauri A. Aaltonen Nii Addy Joanna Aizenberg R. Wayne Alexander Richard M. Amasino Duur K. Aanen Karen Adelman Javier Aizpurua Emil Alexov Stanley H. Ambrose Jorge D. Abad Neil Adger Caroline M. Michael Alfaro Andre L. B. Ambrosio Adam R. Abate Sankar Adhya Ajo-Franklin Juan D. Alfonzo Indu S. Ambudkar Cory Abate-Shen Claire L. Adida Myles Akabas Thomas J. Algeo Amal Amer Abul K. Abbas Becky Adkins Arne N. Akbar Hashim M. Al-Hashimi Daniel L. Ames Jessica Lee Abbate Jess F. Adkins Omar S. Akbari Nageeb Ali Daniel R. Ames Jonathan Abbatt Carrie Adler Erol Akcay Robin R. Ali James B. Ames Elio A. Abbondanzieri Frederick R. Adler Cezmi Akdis Karen Alim Céline Amiez Dorian S. Abbot Ralph Adolphs Mark Akeson A. Paul Alivisatos Sebastian Amigorena Geoffrey W. Abbott Markus Aebi Joshua M. Akey Michael T. Alkire Ariel Amir Karen C. Abbott Philippe V. Afonso Anna Akhmanova Suvarna Alladi David M. Amodio Larry F. Abbott Arash Afraz Ethan Akin Brian F. Allan L. Mario Amzel Nicholas L. Abbott Hervé Agaisse Deji Akinwande David Alland Gynheung An Rasha Abdel Rahman Dritan Agalliu Shizuo Akira Jun Allard Li An Jeffrey N. Agar Irit Akirav Andrew E. Allen Omar Abdel-Wahab Weihua An Ritesh Agarwal Aleksei Aksimentiev Charles N. Allen Jintanat Ananaworanich Ikuro Abe Neus Agell Dag L.
    [Show full text]
  • Meeting Program SID 2019 ANNUAL MEETING
    Meeting Program SID 2019 ANNUAL MEETING 2019 Annual Meeting Scientific 2019 Annual Meeting Program Chairs, Committee Committee on Education Members, and Reviewers Chairs and Committee CHAIRS Members Dan Kaplan, MD/PhD, University of Pittsburgh CHAIRS Ethan Lerner, MD/PhD, Mass General Hospital Heidi Kong, MD, National Insitutes of Health Todd Ridky, MD/PhD, University of Pennsylvania COMMITTEE MEMBERS Lloyd Miller, MD/PhD, Johns Hopkins University COMMITTEE MEMBERS Kevin Wang, MD/PhD, Stanford University My Mahoney, PhD, Thomas Jefferson University Spiro Getsios, PhD, Aspect Biosystems Alexander Marneros, MD/PhD, Harvard University Peggy Myung, MD/PhD, Yale University Robert Dellavalle, MD/PhD, University of Colorado Marjana Tomic-Canic PhD, University of Miami Amanda MacLeod, MD, Duke University Vladimir Botchkarev, MD/PhD, Boston University Cristina de Guzman Strong, PhD, Washington University-St. Louis Tissa Hata, MD, University of California, San Diego Maryam Asgari, MD, Massachusetts General Hospital Ken Tsai, MD/PhD, Moffitt Cancer Center and Paul Nghiem, MD/PhD, University of Washington Research Institute Richard Granstein, MD, Weill Cornell Medical School Sarah Millar, PhD, Mt. Sinai Medical School Matthew Vesley, MD/PhD, Yale University REVIEWERS Anna Di Nardo, MD/PhD Jennifer Gill, MD/PhD, University of Texas Southwestern Carolyn Lee, MD/PhD Jonathan Silverberg, MD/PhD ACKNOWLEDGEMENTS Bogi Andersen, MD The organizers of the 2019 SID Annual Meeting gratefully Kavita Sarin, MD/PhD acknowledge the sponsors, exhibitors, and participants whose Peter Koch, PhD Tiffany C. Scharschmidt, MD attendance has helped to make this meeting possible. Joseph Merola, MD Sakeen Kashem, MD/PhD Thomas Hultsch, MD Amanda MacLeod, MD Liang Deng, MD/PhD Ya-Chieh Hsu, PhD Crystal Aguh, MD Katherine Radek, PhD Paul Nghiem, MD/PhD Alicia Mathers, PhD Raymond Cho, MD Zelma Chiesa, MD Anna Mandinova, MD/PhD Brian Capell, MD/PhD Ryan R.
    [Show full text]
  • Heterogeneity and Evolution in Cancer
    Madrid 23 — 25 Sept 2019 Heterogeneity and Evolution in Cancer Organisers Speakers Fátima Al-Shahrour Alexander R.A. Benjamin D. Guillermina Lozano Anderson Greenbaum Spanish National Cancer Research Centre, Univerity of Texas Anderson CNIO, Madrid, Spain Moffitt Cancer Center and Icahn School of Medicine at Cancer Centre, Houston, US Research Institute, Tampa, Mount Sinai, New York, US Arnold Levine US Marta Łuksza The Simons Center for Systems Biology, Holger Heyn Niko Beerenwinkel Icahn School of Medicine, Institute for Advanced Study, Princeton, US National Centre for Genomic Mount Sinai, New York, US ETH Zürich, Switzerland Analysis, Barcelona, Spain David Posada Solip Park Ivana Bozic Nancy Jenkins School of Biology, Spanish National Cancer Research Centre, University of Washington, US University of Texas MD University of Vigo, Spain CNIO, Madrid, Spain Anderson Cancer Center, Curtis G. Callan Houston, US Carol Prives Raúl Rabadán Princeton University, US Tal Korem Columbia University, Columbia Systems Biology, Columbia New York, US Neal G. Copeland Columbia University Irving University, New York, US University of Texas MD Medical Center, New York, US Benjamin J. Raphael Anderson Cancer Center, Christina Leslie Lewis-Sigler Institute for Houston, US Integrative Genomics, Memorial Sloan Kettering Princeton University, US Christina Curtis Cancer Center, New York, US Stanford University, School of Darryl Shibata Arnold Levine Medicine, Stanford, US Keck School of Medicine of The Simons Center for USC, Los Angeles, US Adolfo Ferrando Systems Biology, Institute for Institute for Cancer Genetics, Advanced Study, Princeton, US Andrea Sottoriva Columbia University Medical Nuria Lopez-Bigas The Institute of Cancer Center, New York, US Research, London, UK Institute for Research in Trevor Graham Biomedicine, Barcelona, Doug Winton Barts Cancer Institute, Spain Cancer Research UK London, UK Scott W.
    [Show full text]
  • Informe 2011 ELEG
    MINISTERIO DE CIENCIA E INNOVACIÓN SUBPROGRAMA RAMON Y CAJAL CONVOCATORIA 2011 Nombre: ACIN PEREZ, REBECA Referencia: RYC-2011-07826 Area: Biomedicina Correo electrónico: [email protected] Titulo: Mitochondrial deficiency and cardiomyopathy: Role of Reactive Oxigen species. Resumen de la Memoria: Mitochondrial diseases are now considered to be among the most common forms of genetic disorders, with a minimum prevalence of 1 in 5000 individuals. They can be caused by mutations in either the nuclear or the mitochondrial DNA (mtDNA). One of the most well characterized clinical presentations is neuromuscular dysfunction, followed by cardiomyopathy, generally in the form of hypertrophic cardiomyopathy. Nowadays there are several clinical treatments approved for mitochondrial diseases. However true treatment is, with some exception, unavailable due to the complexity of the disease and the side effects observed. Several mutations involving mt-tRNA genes (mainly Leu1, Lys and Ile), mt-encoded protein and nuclear encoded protein genes have been associated with cardiomyopathy. Some of these mutations have been deeply studied in a cybrid cell culture model at the biochemistry level. However, very little is known about the signalling pathways that could lead to the development of cardiomyopathy. Mitochondrial physiology and biogenesis are deeply involved in the initiation and progression of the disease, through reactive oxygen species (ROS) production, energy deficiency and decrease in mitochondrial respirasome formation, as initial steps in the formation of the plaques. Recently, it as been demonstrated the role of some mitochondrial biogenesis-related genes, such as PGC1a, in mitochondrial fusion, pointing to the importance of the balance between mitochondrial fusion-fission in the progression of the disease.
    [Show full text]
  • Acknowledgment of Reviewers, 2008
    Proceedings of the National Academy ofPNAS Sciences of the United States of America www.pnas.org Acknowledgment of Reviewers, 2008 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2008. Their generous contribution is deeply appreciated. A Sarah Ades Qais Al-Awqati Marwan Al-shawi Anne Andrews Stuart Aaronson Elizabeth Adkins-Regan Tom Alber Gre´goire Altan-Bonnet David Andrews Alejandro Aballay Frederick Adler Cristina Alberini Karlheinz Altendorf Tim Andrews Cory Abate-Shen Kenneth Adler Heidi Albers Sonia Altizer Timothy Andrews Abul Abbas Lynn Adler Jonathan Alberts Russ Altman Alex Andrianopoulos Antonio Abbate Ralph Adolphs Susan Alberts Eric Altschuler Jean-Michel Ane´ L. Abbott Luciano Adorini Urs Albrecht Burton Altura Phillip Anfinrud Hanna Abboud Johannes Aerts John Alcock N. R. Aluru Klaus Anger Maha Abdellatif Jeffrey Agar Kenneth Aldape Lihini Aluwihare Jacob Anglister Goncalo Abecasis Munna Agarwal Courtney Aldrich Pedro Alzari Wim Annaert Steffen Abel Sunita Agarwal Jane Aldrich David Amaral Brian Annex John Aber Aneel Aggarwal Richard Aldrich Luis Amaral Lucio Annunciato Hinrich Abken Ariel Agmon Kristina Aldridge Richard Amasino Aseem Ansari Carmela Abraham Noam Agmon Maria-Luisa Alegre Christian Amatore Kristi Anseth Edward Abraham Bernard Agranoff Nicole Alessandri-Haber Victor Ambros Eric Anslyn Aneil Agrawal R. McNeill Alexander Stanley Ambrose Kenneth Anthony Soman Abraham Anurag Agrawal Richard Alexander Indu Ambudkar
    [Show full text]
  • Frontiers in Immunomodulation and Cancer Therapy
    Madrid 9 — 11 July 2018 Frontiers in Immunomodulation and Cancer Therapy Organisers Speakers Victoria Aranda Yasmine Belkaid Guido Kroemer Andrea Schietinger The National Institute of The Cordeliers Research Memorial Sloan Kettering Nature, New York, US Health (NIH), Bethesda, US Centre (CRC), Paris, France Cancer Center, NY, US Nabil Djouder Nina Bhardwaj Dan R. Littman Ton Schumacher Icahn School of Medicine at The Helen L. and Martin The Netherlands Cancer Spanish National Cancer Mount Sinai, New York, US S. Kimmel Center for Stem Institute (NIK), Amsterdam, Research Centre (CNIO), Cell Biology, NYU Langone, Netherlands Madrid, Spain Marcus W. US Bosenberg Melody Swartz Yale Cancer Cente, Randy Longman Institute for Molecular Joao Monteiro New Haven, US Weill Cornell Medicine, US Engineering, Nature Medicine, University of Chicago, US New York, US Peter Carmeliet Alberto Mantovani VIB-KU Leuven Center for Humanitas Clinical and Erwin Wagner Cancer Biology, Belgium Research Center, Milan, Spanish National Cancer Marisol Soengas Italy Research Centre (CNIO), Thomas Gajewski Madrid, Spain Spanish National Cancer The University of Chicago, Glenn Merlino Research Centre (CNIO), US Center for Cancer Research, Jennifer Wargo Madrid, Spain NCI, Bethesda, US The University of Texas Carola García MD Anderson Cancer Laurence Zitvogel de Vinuesa Graham Pawelek Center, Houston, US John Curtin School of The University of Tübingen, Gustave Roussy Institute, Medical Research, Germany Laurence Zitvogel Villejuif, France The Australian National Gustave
    [Show full text]
  • Trustees' Report and Financial Statements 2015-2016
    TRUSTEES’ REPORT AND FINANCIAL STATEMENTS 1 Trustees’ report and financial statements For the year ended 31 March 2016 2 TRUSTEES’ REPORT AND FINANCIAL STATEMENTS Trustees Executive Director The Trustees of the Society are the Dr Julie Maxton members of its Council, who are elected Statutory Auditor by and from the Fellowship. Council is Deloitte LLP chaired by the President of the Society. Abbots House During 2015/16, the members of Council Abbey Street were as follows: Reading President RG1 3BD Sir Paul Nurse* Bankers Sir Venki Ramakrishnan** The Royal Bank of Scotland Treasurer 1 Princes Street Professor Anthony Cheetham London EC2R 8BP Physical Secretary Professor Alexander Halliday Investment Managers Rathbone Brothers PLC Foreign Secretary 1 Curzon Street Sir Martyn Poliakoff CBE London Biological Secretary W1J 5FB Sir John Skehel Internal Auditors Members of Council PricewaterhouseCoopers LLP Sir John Beddington CMG* Cornwall Court Professor Andrea Brand 19 Cornwall Street Sir Keith Burnett** Birmingham Professor Michael Cates B3 2DT Dame Athene Donald DBE* Professor George Efstathiou** Professor Brian Foster** Professor Carlos Frenk* Registered Charity Number 207043 Professor Uta Frith DBE Registered address Professor Joanna Haigh 6 – 9 Carlton House Terrace Dame Wendy Hall DBE London SW1Y 5AG Dr Hermann Hauser Dame Frances Kirwan DBE* royalsociety.org Professor Ottoline Leyser CBE* Professor Angela McLean Dame Georgina Mace CBE Professor Roger Owen* Dame Nancy Rothwell DBE Professor Stephen Sparks CBE Professor Ian Stewart Dame Janet Thornton DBE Professor Cheryll Tickle** Dr Richard Treisman** Professor Simon White** * Until 30 November 2015 ** From 30 November 2015 Cover image Tadpoles overhead by Bert Willaert, Belgium. TRUSTEES’ REPORT AND FINANCIAL STATEMENTS 3 Contents President’s foreword ...............................................
    [Show full text]